The NRC at the Canadian Cancer Immunotherapy Consortium Symposium

December 13, 2017 — December 15, 2017 — Montréal, Quebec

NRC experts will share their latest research and exchange ideas with their peers at the Canadian Cancer Immunotherapy Consortium symposium in Montreal. Specifically, they will discuss viral vector design and production, which are key tools for cell therapy.

Connect with them to discover how the NRC's programs, expertise, facilities and technologies can support organizations developing innovative cancer treatments.

NRC expert Where to connect
Mehdy Elahi
Research officer
Viral vector production
Telephone: 514-496-2747
Email: Mehdy.Elahi@nrc-cnrc.gc.ca
LinkedIn: Mehdy Elahi
POSTER: A combination of replicating/non-disseminating adenovirus expressing a suicide gene and cancer specific antigens reduces tumor burden in a mouse model for melanoma
Parminder Chahal
Research officer
Viral vector production
Telephone: 514-496-6973
Email: Parminder.Chahal@nrc-cnrc.gc.ca
LinkedIn: Parminder Chahal
POSTER: Lentivirus production strategies by HEK293 cell-based packaging- and producer-cell lines growing in suspension and in a serum-free medium
Aziza Manceur
Research officer
Cell culture scale-up
Telephone: 438-988-1289
Email: Aziza.Manceur@nrc-cnrc.gc.ca
LinkedIn: Aziza Manceur

POSTER: Lentiviral vector production in bioreactors using stable producer cell lines in perfusion mode

Rénald Gilbert
Team leader
Viral vector production
Telephone: 514-496-5308
Email: Rénald.Gilbert@nrc-cnrc.gc.ca
LinkedIn: Rénald Gilbert

Rénald leads the Viral vector production team. Connect with him if you would like to know more about the NRC's:

Sven Ansorge
Team leader
Cell culture scale-up
Telephone: 514-283- 3915
Email: Sven.Ansorge@nrc-cnrc.gc.ca
LinkedIn: Sven Ansorge

Sven leads the Cell culture scale-up team. Connect with him if you would like to know more about the NRC's:

Date modified: